We are live on ! Find out more
BG

Bahl & Gaynor Portfolio holdings

AUM $19.8B
1-Year Est. Return 19.53%
This Fund
S&P 500
This Quarter Est. Return
+16.44%
1 Year Est. Return
+19.53%
3 Year Est. Return
+63.97%
5 Year Est. Return
+84.2%
10 Year Est. Return
+296.44%
AUM
$13.3B
AUM Growth
+$1.82B
Cap. Flow
+$65.9M
Cap. Flow %
0.5%
Top 10 Hldgs %
32.36%
Holding
350
New
21
Increased
125
Reduced
153
Closed
21

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$72.8M
2
ABBV icon
AbbVie
ABBV
+$59.8M
3
PG icon
Procter & Gamble
PG
+$53.3M
4
VZ icon
Verizon
VZ
+$26.4M
5
AVGO icon
Broadcom
AVGO
+$19.9M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$79.9M
2
MCD icon
McDonald's
MCD
+$64.5M
3
EL icon
Estee Lauder
EL
+$57.4M
4
O icon
Realty Income
O
+$20.5M
5
AAPL icon
Apple
AAPL
+$18.6M

Sector Composition

Rank Sector Weight
1 Technology 21.17%
2 Healthcare 15.36%
3 Financials 13.42%
4 Consumer Staples 9.92%
5 Industrials 9.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AJG icon
101
Arthur J. Gallagher & Co
AJG
$63.6B
$9.79M 0.07%
100,419
-28,087
-22% -$2.49M
HPQ icon
102
HP
HPQ
$27.5B
$9.68M 0.07%
555,178
-14,988
-3% -$238K
FISV
103
Fiserv Inc
FISV
$27.9B
$9.48M 0.07%
97,078
-120
-0.1% -$12.1K
BRK.B icon
104
Berkshire Hathaway Class B
BRK.B
$1.13T
$9.37M 0.07%
52,511
-3,489
-6% -$637K
EHC icon
105
Encompass Health
EHC
$12.4B
$8.89M 0.07%
180,493
+1,491
+0.8% +$80.5K
ELS icon
106
Equity Lifestyle Properties
ELS
$12.6B
$8.77M 0.07%
140,324
+10,195
+8% +$626K
HAS icon
107
Hasbro
HAS
$13.2B
$8.52M 0.06%
113,694
+27,523
+32% +$1.99M
CSGS
108
DELISTED
CSG Systems International
CSGS
$8.45M 0.06%
204,166
-712
-0.3% -$32.6K
LOW icon
109
Lowe's Companies
LOW
$125B
$8.33M 0.06%
61,660
+1,232
+2% +$141K
BBY icon
110
Best Buy
BBY
$17.3B
$7.81M 0.06%
89,539
+1,920
+2% +$146K
PRGS icon
111
Progress Software
PRGS
$1.76B
$7.53M 0.06%
194,382
+124,526
+178% +$4.74M
MZTI
112
The Marzetti Company
MZTI
$3.11B
$7.53M 0.06%
48,586
+26,736
+122% +$3.89M
HMN icon
113
Horace Mann Educators
HMN
$2.11B
$7.47M 0.06%
203,292
-784
-0.4% -$27.6K
MDC
114
DELISTED
M.D.C. Holdings, Inc.
MDC
$7.43M 0.06%
224,904
+13,187
+6% +$364K
CONE
115
DELISTED
CyrusOne Inc Common Stock
CONE
$7.14M 0.05%
98,187
+178
+0.2% +$12.7K
DOX icon
116
Amdocs
DOX
$6.22B
$7.13M 0.05%
117,172
+8,163
+7% +$504K
JKHY icon
117
Jack Henry & Associates
JKHY
$11.1B
$7.04M 0.05%
38,276
+748
+2% +$130K
COR
118
DELISTED
Coresite Realty Corporation
COR
$6.97M 0.05%
57,575
-4,921
-8% -$592K
MSA icon
119
Mine Safety
MSA
$7.49B
$6.93M 0.05%
60,569
-84
-0.1% -$9.34K
DOV icon
120
Dover
DOV
$28.4B
$6.76M 0.05%
70,031
-290
-0.4% -$26.8K
FR icon
121
First Industrial Realty Trust
FR
$8.44B
$6.65M 0.05%
172,943
+17,703
+11% +$648K
SLP icon
122
Simulations Plus
SLP
$371M
$6.3M 0.05%
105,363
-1,831
-2% -$80.6K
OKE icon
123
Oneok
OKE
$54.5B
$6.3M 0.05%
189,533
-60,964
-24% -$1.99M
CE icon
124
Celanese
CE
$4.82B
$6.25M 0.05%
72,389
+706
+1% +$58.8K
CBU icon
125
Community Bank
CBU
$3.41B
$6.17M 0.05%
108,113
-65
-0.1% -$3.82K

Similar funds

Bahl & Gaynor's Q2 2020 Portfolio in Review

As of Q2 2020, Bahl & Gaynor held 350 positions worth $13.3B, up 16% from $11.5B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Bahl & Gaynor's Q2 2020 filing shows 21 new, 125 increased, 153 reduced and 21 closed positions. Its largest new stake was Otis Worldwide: 90,609 shares worth $5.15M. The largest sale was Pfizer, an estimated $79.9M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • Bahl & Gaynor's largest Q2 2020 buy was Otis Worldwide: 90,609 shares worth $5.15M.
  • Bahl & Gaynor added most to Merck in Q2 2020, an estimated $72.8M increase.
  • Bahl & Gaynor's biggest Q2 2020 reduction was Pfizer, cutting an estimated $79.9M.
  • Bahl & Gaynor fully exited Interparfums in Q2 2020, selling an estimated $4.84M.
  • Bahl & Gaynor's ten largest holdings make up 32% of its $13.3B portfolio in Q2 2020.
  • Bahl & Gaynor opened 21 new positions and closed 21 in Q2 2020.
  • Bahl & Gaynor's portfolio value rose 16% quarter-over-quarter to $13.3B.

Based on Bahl & Gaynor's 13F filing for Q2 2020, filed 13 Aug 2020.